Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi Center, Open Label, Single Arm Trial Evaluating Panitumumab in Combination With FOLFIRI Therapy Following First Line FOLFOX and Bevacizumab Treatment of Metastatic Colorectal Cancer

NCT00411450 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00411450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00411450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi Center, Open Label, Single Arm Trial Evaluating Panitumumab in Combination With FOLFIRI Therapy Following First Line FOLFOX and Bevacizumab Treatment of Metastatic Colorectal Cancer
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2006
Completion date
October 31, 2010
Enrollment
116 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, colon cancer, colorectal cancer, metastatic cancer, metastatic colorectal cancer, oncology, rectal cancer